Anticancer drug-treated fibroblasts modulate colon cancer cell behavior through lysophosphatidic acid (LPA) receptor-mediated signaling

Key Points

• Colon cancer cell behavior is influenced by fibroblasts treated with anticancer drugs, and this effect is mediated by lysophosphatidic acid (LPA).
• The study highlights the role of LPA receptor-mediated signaling in the interaction between fibroblasts and colon cancer cells.
• Observational analysis focusing on fibroblast-cancer interactions reveals essential insights for potential therapies.
• These findings underscore the importance of targeting fibroblasts in cancer treatment strategies.],